483 Ascent Pharmaceuticals Oct 2020

483 Ascent Pharmaceuticals Oct 2020

Bijoy Panicker FDA$119.00 - Available Now

FDA investigators audited the Ascent Pharmaceuticals - Central Islip, NY, United States facility and issued inspectional observations (via FDA 483) on 13 Oct 2020.

Product details

  • Category: Human Drugs
  • Inspection end: 13 Oct 2020
  • Location: Central Islip, United States
  • FEI: 3009518416
Add To Cart